Cluster Information | Plasmid Cluster ID | C539 |
Reference Plasmid | NZ_CP027600.1 | |
Reference Plasmid Size | 120604 | |
Reference Plasmid GC Content | 0.53 | |
Reference Plasmid Mobility Type | conjugative |
mutid | gname | pos | count | tissue | frequnt | biotype | consequence | impact | nucchange | aachange |
---|---|---|---|---|---|---|---|---|---|---|
M0168104 | KFKPOEHG_00078 | 71010 | 3 | Gut | 0.23 | protein_coding | synonymous_variant | LOW | 180C>T | Thr60Thr |
M0168105 | KFKPOEHG_00075 | 72116 | 3 | Gut | 0.23 | protein_coding | upstream_gene_variant | MODIFIER | -4110C>T | None |
Gene Name | vf_gene_id | vf_name | identity | evalue | qstart | qend | query_coverage | subject_coverage | vf_category | gene_description | condition |
---|---|---|---|---|---|---|---|---|---|---|---|
KFKPOEHG_00027 | VFG042365 | EspI, SPATE | 77.4 | 0 | 25 | 1387 | 0.9827 | 1 | Effector delivery system | hypothetical protein | prediction |
KFKPOEHG_00122 | VFG043980 | Colicin Ib | 98.9 | 1.2e-247 | 1 | 463 | 1.0 | 0.7396 | Exotoxin | colicin-like pore-forming protein | prediction |
Gene Name | compound | identity | evalue | qstart | qend | query_coverage | subject_coverage | group |
---|---|---|---|---|---|---|---|---|
KFKPOEHG_00108 | Mercury (Hg) | 78.2 | 4.9e-33 | 1 | 78 | 1.0000 | 1.0000 | experiment |
KFKPOEHG_00109 | Mercury (Hg) | 82.6 | 1.3e-48 | 1 | 120 | 1.0083 | 1.0000 | experiment |
KFKPOEHG_00110 | Mercury (Hg) | 89.5 | 1.3e-229 | 1 | 455 | 1.0000 | 0.8111 | experiment |
KFKPOEHG_00113 | Mercury (Hg) | 90.1 | 7e-39 | 1 | 91 | 1.0000 | 1.0000 | experiment |
KFKPOEHG_00114 | Mercury (Hg) | 100 | 1.3e-62 | 19 | 134 | 0.8657 | 1.0000 | experiment |
KFKPOEHG_00115 | Mercury (Hg) | 93.8 | 4e-73 | 1 | 144 | 1.0000 | 1.0000 | experiment |
KFKPOEHG_00108 | Mercury (Hg) | 83.3 | 2.7e-32 | 1 | 78 | 1.0000 | 1.0000 | prediction |
KFKPOEHG_00109 | Mercury (Hg) | 91.7 | 5.5e-53 | 1 | 120 | 1.0000 | 1.0000 | prediction |
KFKPOEHG_00110 | Mercury (Hg), Phenylmercury Acetate [class: Organo-mercury] | 100 | 1.6e-254 | 1 | 455 | 1.0000 | 0.8067 | prediction |
KFKPOEHG_00113 | Mercury (Hg) | 100 | 6.3e-41 | 1 | 91 | 1.0000 | 0.8835 | prediction |
KFKPOEHG_00114 | Mercury (Hg) | 90.3 | 1.2e-64 | 1 | 134 | 1.0000 | 1.0000 | prediction |
KFKPOEHG_00115 | Mercury (Hg) | 100 | 4.3e-76 | 1 | 144 | 1.0000 | 0.7619 | prediction |
Gene Name | aro_accession | identity | evalue | qstart | qend | query_coverage | subject_coverage | drug_class | amr_gene_family | resistance_mechanism |
---|---|---|---|---|---|---|---|---|---|---|
KFKPOEHG_00095 | ARO:3000873 | 100 | 5.12e-208 | 1 | 286 | 1.0000 | 1.0000 | monobactam | TEM beta-lactamase | antibiotic inactivation |
KFKPOEHG_00097 | ARO:3002641 | 98.5 | 6.49e-208 | 1 | 271 | 1.0000 | 1.0000 | aminoglycoside antibiotic | APH(3') | antibiotic inactivation |
KFKPOEHG_00100 | ARO:3002660 | 100 | 4.41e-183 | 1 | 247 | 0.9686 | 0.8885 | aminoglycoside antibiotic | APH(6) | antibiotic inactivation |
KFKPOEHG_00101 | ARO:3002639 | 99.6 | 5.98e-202 | 1 | 267 | 1.0000 | 1.0000 | aminoglycoside antibiotic | APH(3'') | antibiotic inactivation |
KFKPOEHG_00102 | ARO:3000412 | 99.6 | 8.29e-186 | 1 | 271 | 1.0000 | 1.0000 | sulfonamide antibiotic | sulfonamide resistant sul | antibiotic target replacement |
KFKPOEHG_00118 | ARO:3000165 | 99.7 | 7.17e-278 | 1 | 390 | 0.9774 | 0.9198 | tetracycline antibiotic | major facilitator superfamily (MFS) antibiotic efflux pump | antibiotic efflux |
Gene Name | phi_molconn_id | host gene_name | identity | evalue | qstart | qend | query_coverage | subject_coverage | host_descripton | disease_name | function | phenotype_of_mutant |
---|
Gene Name | cazy_id | identity | evalue | qstart | qend | query_coverage | subject_coverage |
---|---|---|---|---|---|---|---|
KFKPOEHG_00070 | AKF16924.1|GH23 | 100 | 9.46e-114 | 1 | 157 | 1 | 1 |
Gene Name | tcid | identity | evalue | qstart | qend | query_coverage | subject_coverage | class_field | class_term | subclass | subclass_term | family | family_term |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
KFKPOEHG_00020 | 3.A.7.10.1 | 79.8 | 0 | 1 | 724 | 0.9439 | 7.5417 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.7 | The Type IV (Conjugal DNA-Protein Transfer or VirB) Secretory Pathway (IVSP) Family |
KFKPOEHG_00022 | 3.A.7.10.1 | 76.2 | 7e-189 | 1 | 399 | 0.9301 | 4.1563 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.7 | The Type IV (Conjugal DNA-Protein Transfer or VirB) Secretory Pathway (IVSP) Family |
KFKPOEHG_00033 | 1.E.53.1.10 | 92.9 | 6.3e-17 | 9 | 50 | 0.8400 | 0.9767 | 1 | Channels/Pores | 1.E | Holins | 1.E.53 | The Toxic Hok/Gef Protein (Hok/Gef) Family |
KFKPOEHG_00053 | 3.A.7.10.1 | 76.5 | 2.2e-139 | 1 | 324 | 1.0000 | 3.4063 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.7 | The Type IV (Conjugal DNA-Protein Transfer or VirB) Secretory Pathway (IVSP) Family |
KFKPOEHG_00054 | 3.A.7.10.1 | 70.3 | 5.2e-90 | 6 | 227 | 0.9610 | 2.2917 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.7 | The Type IV (Conjugal DNA-Protein Transfer or VirB) Secretory Pathway (IVSP) Family |
KFKPOEHG_00055 | 3.A.7.10.1 | 74.1 | 5e-41 | 1 | 116 | 1.0000 | 1.1979 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.7 | The Type IV (Conjugal DNA-Protein Transfer or VirB) Secretory Pathway (IVSP) Family |
KFKPOEHG_00057 | 3.A.7.10.1 | 71.3 | 1.3e-39 | 1 | 94 | 0.9792 | 0.9792 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.7 | The Type IV (Conjugal DNA-Protein Transfer or VirB) Secretory Pathway (IVSP) Family |
KFKPOEHG_00058 | 3.A.7.10.1 | 79 | 1.1e-177 | 4 | 379 | 0.9843 | 3.9167 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.7 | The Type IV (Conjugal DNA-Protein Transfer or VirB) Secretory Pathway (IVSP) Family |
KFKPOEHG_00059 | 3.A.7.10.1 | 79 | 1.3e-124 | 1 | 271 | 0.9748 | 2.8021 | 3 | Primary Active Transporters | 3.A | P-P-bond-hydrolysis-driven transporters | 3.A.7 | The Type IV (Conjugal DNA-Protein Transfer or VirB) Secretory Pathway (IVSP) Family |
KFKPOEHG_00108 | 1.A.72.5.1 | 100 | 1.8e-39 | 1 | 78 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.72 | The Mercuric Ion Pore (Mer) Superfamily |
KFKPOEHG_00113 | 1.A.72.3.1 | 90.1 | 2.6e-37 | 1 | 91 | 1.0000 | 1.0000 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.72 | The Mercuric Ion Pore (Mer) Superfamily |
KFKPOEHG_00114 | 1.A.72.3.1 | 87.9 | 3.5e-54 | 19 | 134 | 0.8657 | 1.2747 | 1 | Channels/Pores | 1.A | α-Type Channels | 1.A.72 | The Mercuric Ion Pore (Mer) Superfamily |
KFKPOEHG_00118 | 2.A.1.2.4 | 100 | 2.4e-223 | 1 | 399 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.1 | The Major Facilitator Superfamily (MFS) |
KFKPOEHG_00119 | 2.A.7.3.67 | 100 | 1.8e-159 | 1 | 294 | 1.0000 | 1.0000 | 2 | Electrochemical Potential-driven Transporters | 2.A | Porters (uniporters, symporters, antiporters) | 2.A.7 | The Drug/Metabolite Transporter (DMT) Superfamily |
KFKPOEHG_00122 | 1.C.1.1.2 | 99.1 | 9.3e-248 | 1 | 463 | 1.0000 | 0.7396 | 1 | Channels/Pores | 1.C | Pore-Forming Toxins (Proteins and Peptides) | 1.C.1 | The Channel-forming Colicin (Colicin) Family |
KFKPOEHG_00123 | 8.B.24.2.1 | 97.3 | 1.2e-55 | 1 | 110 | 0.9565 | 0.8661 | 8 | Accessory Factors Involved in Transport | 8.B | Ribosomally synthesized protein/peptide toxins/agonists that target channels and carriers | 8.B.24 | The Colicin Immunity Protein (ColIP) Functional Family |